glp-1 weight loss non diabetic cost McKee's proposed FY2027 budget drops drugs for from Medicaid • Rhode Island Current GLP-1 Costs Explained: Managing Coverage

Tapering versus abrupt cessation The clinical trials did not specifically study tapering protocols, but physiological principles suggest a gradual dose reduction may produce a smoother transition than abrupt cessation

Lack of modulation by short-term fasting and some other ingestive peptides that may interact with GLP-1, including leptin, glucagon, insulin, neuropeptide Y, and melanin-concentrating hormone

But in a twist this August, a separate part of North Carolinas government allowed the Medicaid program to start covering the drugs for weight loss not just diabetes for the states poorest residents, who are disproportionately affected by obesity and related diseases

Why injectable forms are considered safer Injectable semaglutide (Ozempic, Wegovy) and injectable tirzepatide (Mounjaro, Zepbound) are administered subcutaneously

We're continuing to keep a close eye on the progress of this litigation